Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 06/12/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 393 publications

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.

Condition: Adults with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Journal: Journal of hematology & oncology
Treatment Used: KTE-X19
Number of Patients: 55
Published: December 09, 2022

Extracorporeal cytokine removal in chimeric antigen receptor T-cell therapy associated cytokine release syndrome in patient with acute lymphoblastic leukemia. Case report.

Condition: B-Cell Acute Lymphoblastic Leukemia/Cytokine Release Syndrome/Shock/Multiple Orgnan Failure
Journal: Terapevticheskii arkhiv
Treatment Used: Cytokine Removal and Hemodiafiltration Plus CAR-T Therapy
Number of Patients: 1
Published: October 26, 2022

Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study.

Condition: Childhood Acute Lymphoblastic Leukemia (ALL)
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Treatment Used: Intensive Chemotherapy with Dasatinib
Number of Patients: 7640
Published: October 08, 2022

CT-028 Clofarabine and Total Body Irradiation as a Conditioning Regimen for Allogeneic Stem Cell Transplantation in High-Risk Acute Leukemia.

Condition: High-Risk Acute Leukemia
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Clofarabine and Total Body Irradiation (TBI)
Number of Patients: 23
Published: September 27, 2022

ALL-220 Azacitidine in Combination With Venetoclax Maintenance Post Allogeneic Hematopoietic Cell Transplantation in T-Cell Acute Lymphoblastic Leukemia.

Condition: T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Azacitidine in Combination With Venetoclax Maintenance Post Allogeneic Hematopoietic Cell Transplantation (allo_HSCT)
Number of Patients: 4
Published: September 27, 2022

Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective.

Condition: Acute Lymphoblastic Leukemia (ALL)
Journal: Expert review of hematology
Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
Number of Patients: 0
Published: September 15, 2022

Dynamics of minimal residual disease defines a novel risk-classification and the role of allo-HSCT in adult Ph-negative B-cell acute lymphoblastic leukemia.

Condition: Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)
Journal: Leukemia & lymphoma
Treatment Used: Allogenic Hematopoietic Stem Cell Transplantation (allo-HSCT)
Number of Patients: 134
Published: September 13, 2022

A Retrospective Cohort Study of the Efficacy, Safety, and Clinical Value of 6-TG versus 6-MP Maintenance Therapy in Children with Acute Lymphoblastic Leukemia.

Condition: Children with Acute Lymphoblastic Leukemia (ALL)
Journal: BioMed research international
Treatment Used: 6-TG Maintenance Therapy
Number of Patients: 57
Published: September 01, 2022

Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission.

Condition: Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Journal: Bone marrow transplantation
Treatment Used: Pediatric-Type Chemotherapy
Number of Patients: 127
Published: August 30, 2022

Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

Condition: Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia (ALL)
Journal: Transplantation and cellular therapy
Treatment Used: Allogeneic Stem Cell Transplantation (HCT)
Number of Patients: 542
Published: August 28, 2022

CAR-T therapy as a consolidation in remission B-ALL patients with poor prognosis.

Condition: B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Journal: Cancer reports (Hoboken, N.J.)
Treatment Used: Chimeric Antigen Receptor (CAR)-T Cell Therapy
Number of Patients: 0
Published: August 22, 2022

FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.

Condition: Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)
Journal: The oncologist
Treatment Used: Brexucabtagene Autoleucel (brexu-cel)
Number of Patients: 78
Published: August 19, 2022
Showing 1-12 of 393

Last Updated: 06/12/2023